Search

PROCEPT BioRobotics Corp

Open

SectorHealthcare

20.22 -4.53

Overview

Share price change

24h

Current

Min

19.37

Max

21.79

Key metrics

By Trading Economics

Income

-27M

-58M

Sales

11M

94M

EPS

-0.47

Profit margin

-61.905

Employees

888

EBITDA

5.1M

-24M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+16.34% upside

Market Stats

By TradingEconomics

Market Cap

67M

1.1B

Previous open

24.75

Previous close

20.22

PROCEPT BioRobotics Corp Chart

Past performance is not a reliable indicator of future results.

Related News

5 Nov 2026, 21:04 UTC

News

PROCEPT BioRobotics shares are sharply lower after a Leerink Partners report maintained a Market Perform rating and raised its price target to $22.

4 Nov 2026, 22:02 UTC

News

PROCEPT BioRobotics reports Q3 net loss of $26.5 million and revenue of $98.3 million, both missing analyst expectations, prompting a sharp decline in shares after-market.

3 Nov 2026, 21:07 UTC

PROCEPT BioRobotics Corporation shares are advancing, rebounding from an early dip and reaching a peak return late in the session, significantly above its 20-day moving average.

30 Oct 2026, 20:03 UTC

PROCEPT BioRobotics Corporation shares fell sharply, retracing from an early high and reaching a session low just before mid-afternoon.

28 Oct 2026, 20:07 UTC

PROCEPT BioRobotics Corporation shares are advancing, currently positioned above its 20-day moving average and near the upper end of its one-month trading range.

26 Oct 2026, 20:07 UTC

Procept Biorobotics Corp shares are declining, pulling back from earlier gains, while remaining above the 20-day moving average and near the upper end of its one-month range.

22 Oct 2026, 20:02 UTC

Procept Biorobotics Corp shares are sharply higher amid broader market upward momentum, marking a divergence from recent trends of higher daily closes since Wednesday.

21 Oct 2026, 20:07 UTC

Procept Biorobotics Corp shares are declining, continuing a downward trend since Tuesday's close, amid overall market declines across various sectors.

19 Oct 2026, 19:46 UTC

Procept Biorobotics Corp is trading higher, previously peaking above 3% before a slight retracement, significantly exceeding its 20-day moving average.

16 Oct 2026, 20:07 UTC

Procept Biorobotics Corp shares fell sharply, finishing at their lowest point of the day amid a challenging market backdrop and remaining below their 20-day moving average.

15 Oct 2026, 20:07 UTC

Procept Biorobotics Corp shares are advancing, aligning with a broader market trend that peaked at a cumulative return of 3.77% on Thursday.

14 Oct 2026, 20:02 UTC

Procept Biorobotics Corp shares fell sharply, reversing recent upward momentum and indicating a shift from higher daily closes observed since Tuesday.

13 Oct 2026, 20:08 UTC

Procept Biorobotics Corp shares fell sharply, reaching a notable low before a failed recovery attempt, contributing to a cumulative decline since Monday's close.

12 Oct 2026, 20:01 UTC

News

Procept Biorobotics appointed Dr. Michael Mack as an independent director amid a shareholder lawsuit, with shares sharply higher, breaking a recent trend.

9 Oct 2026, 23:10 UTC

Procept Biorobotics Corp shares advanced during after-market hours, rising significantly and currently positioned above its 20-day moving average.

7 Oct 2026, 20:07 UTC

News

Procept Biorobotics Corp shares are advancing after Barclays initiated coverage with an Overweight rating and a $30 price target.

5 Oct 2026, 20:01 UTC

Procept Biorobotics Corp is trading higher, having reached a peak return before pulling back slightly, reflecting notable gains near its one-month trading range.

2 Oct 2026, 20:07 UTC

Procept Biorobotics Corp shares are higher amid a broader market rise, influenced by weak job growth data and declining U.S. Treasury yields.

1 Oct 2026, 20:02 UTC

Procept Biorobotics Corp shares fell sharply, breaking a streak of higher daily closes that began after Wednesday's close.

29 Sept 2026, 20:01 UTC

Procept Biorobotics Corp is sharply higher amid a broader market backdrop, despite currently trading lower and diverging from recent upward momentum.

28 Sept 2026, 19:46 UTC

Procept Biorobotics Corp is trading slightly higher, showing modest gains since Friday's close, despite remaining below its 20-day moving average.

25 Sept 2026, 22:20 UTC

Procept Biorobotics Corp has advanced in after-market trading, rebounding sharply after six consecutive daily declines, though still below its 20-day moving average.

24 Sept 2026, 20:07 UTC

Procept Biorobotics Corp's shares fell sharply, marking the fifth consecutive day of declines and closing below the 20-day moving average.

16 Sept 2026, 20:10 UTC

Macro Event

Procept Biorobotics Corp is trading modestly higher, following the Federal Reserve's 25 basis point rate hike amid ongoing inflation concerns and market volatility.

15 Sept 2026, 23:21 UTC

Procept Biorobotics Corp shares are higher in after-market trading, despite broader market pressures from rising Treasury yields. No specific news was identified.

11 Sept 2026, 20:08 UTC

Procept Biorobotics Corp is higher today, recovering from an earlier dip. The stock remains below its 20-day moving average after three lower closes.

10 Sept 2026, 20:31 UTC

Procept Biorobotics Corp shares are higher in after-market hours following increased trading, reversing a trend of declines over the past three sessions.

9 Sept 2026, 20:07 UTC

News

Procept Biorobotics shares are declining amid a class action lawsuit alleging misleading sales practices and inflated financial reporting.

8 Sept 2026, 20:03 UTC

News

Procept Biorobotics Corp shares are lower as multiple securities class action lawsuits allege misleading inventory and sales practices, impacting investor sentiment.

4 Sept 2026, 20:02 UTC

Procept Biorobotics shares are higher today, reflecting overall market strength since Thursday's close. No specific company news was identified to explain the movement.

Peer Comparison

Price change

PROCEPT BioRobotics Corp Forecast

Price Target

By TipRanks

16.34% upside

12 Months Forecast

Average 25.2 USD  16.34%

High 30 USD

Low 21 USD

Based on 9 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

9 ratings

3

Buy

5

Hold

1

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat